Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New insights into peripheral T-cell lymphomas

J F DeCoteau1, M E Kadin

  • 1Beth Israel Hospital, Boston, Massachusetts, USA.

Current Opinion in Oncology
|September 1, 1995
PubMed
Summary

Peripheral T-cell lymphomas are diverse cancers lacking a unified classification. Ongoing research aims to define these tumors better, paving the way for improved diagnosis and prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Reed-Sternberg Cell, An Activated T-cell? The Evidence Has Come Full Circle.

Leukemia & lymphoma·2016
Same author

KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma.

The British journal of dermatology·2016
Same author

CD30-rich transformed mycosis fungoides or anaplastic large cell lymphoma? How to get it right.

The British journal of dermatology·2015
Same author

Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance.

Oncogenesis·2014
Same author

γδ T-cell-rich variants of pityriasis lichenoides and lymphomatoid papulosis: benign cutaneous disorders to be distinguished from aggressive cutaneous γδ T-cell lymphomas.

The British journal of dermatology·2014
Same author

Yeast two-hybrid screening of cyclic peptide libraries using a combination of random and PI-deconvolution pooling strategies.

Protein engineering, design & selection : PEDS·2012

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of cancers originating from mature T lymphocytes.
  • Current classification systems for PTCLs lack universal acceptance and clinical consensus.
  • Understanding the underlying pathogenetic mechanisms is crucial for defining distinct PTCL entities.

Purpose of the Study:

  • To review the current state of peripheral T-cell lymphoma classification.
  • To highlight recent advancements in understanding PTCL pathobiology.
  • To discuss the future directions for developing a unified and clinically relevant classification system.

Main Methods:

  • Review of existing literature on peripheral T-cell lymphoma.
  • Analysis of recent pathogenetic studies.
  • Synthesis of data to identify emerging patterns and entities.

Main Results:

  • Peripheral T-cell lymphomas represent a morphologically and biologically diverse set of malignancies.
  • Significant progress has been made in identifying distinct PTCL entities based on molecular and pathogenetic insights.
  • Existing classifications remain challenging due to heterogeneity and limited predictive value.

Conclusions:

  • A unified classification system for peripheral T-cell lymphoma is currently lacking but is an active area of research.
  • Future studies focusing on pathogenetic mechanisms are essential for developing a reproducible and biologically relevant classification.
  • An improved classification system is anticipated to enhance clinical behavior prediction and patient prognosis.

Related Experiment Videos